2025 Purple Reenrollment Group

Disease Programs Open for 2025 Reenrollment: Purple Group

  • Acid Sphingomyelinase Deficiency Financial Assistance Program
  • Acromegaly Copay Assistance Program
  • Acute Myeloid Leukemia Copay Assistance Program
  • Alpha-1 Antitrypsin Deficiency Financial Assistance Program
  • Amyotrophic Lateral Sclerosis Financial Assistance Program
  • Atopic Dermatitis Copay Assistance Program
  • Atypical Hemolytic Uremic Syndrome Financial Assistance Program
  • Biliary Tract Cancer Copay Assistance Program
  • Bladder Cancer Copay Assistance Program
  • Breast Cancer Copay Assistance Program
  • Chronic Granulomatous Disease Financial Assistance Program
  • Chronic Inflammatory Demyelinating Polyneuropathy Financial Assistance Program
  • Chronic Obstructive Pulmonary Disease Copay Assistance Program
  • Cold Agglutinin Disease Financial Assistance Program
  • Crohn’s Disease Copay Assistance Program
  • Cystic Fibrosis Copay Assistance Program
  • Cystinosis Financial Assistance Program
  • Duchenne Muscular Dystrophy Financial Assistance Program
  • Fabry Disease Financial Assistance Program
  • Gaucher Disease Financial Assistance Program
  • Gout Financial Assistance Program
  • Hepatocellular Carcinoma Copay Assistance Program
  • Hereditary Angioedema Financial Assistance Program
  • Hunter Syndrome Financial Assistance Program
  • Hypophosphatasia Financial Assistance Program
  • Hypophosphatemia Financial Assistance Program
  • Idiopathic Hypersomnia Financial Assistance Program
  • Idiopathic Pulmonary Fibrosis Copay Assistance Program
  • Immunoglobulin A Nephropathy Financial Assistance Program
  • Lambert-Eaton Myasthenic Syndrome Financial Assistance Program
  • Long-Chain Fatty Acid Oxidation Disorders Financial Assistance Program
  • Lysosomal Acid Lipase Deficiency Financial Assistance Program
  • Mucopolysaccharidosis Type I – MPS I Financial Assistance Program
  • MPS VII – Sly Syndrome Financial Assistance Program
  • Multiple Sclerosis Copay Assistance Program
  • Myasthenia Gravis Financial Assistance Program
  • Neurofibromatosis Financial Assistance Program
  • Neuromyelitis Optica Spectrum Disorder Financial Assistance Program
  • Nonalcoholic Steatohepatitis Financial Assistance Program
  • Non-Small Cell Lung Cancer Copay Program
  • Nontuberculous Mycobacterial Lung Disease Copay Assistance Program
  • Ovarian Cancer Copay Assistance Program
  • Pancreatic Cancer Copay Assistance Program
  • Parkinson’s Disease Copay Assistance Program
  • Paroxysmal Nocturnal Hemoglobinuria Financial Assistance Program
  • Pompe Disease Financial Assistance Program
  • Post-Traumatic Stress Disorder Financial Assistance Program
  • Primary Biliary Cholangitis Financial Assistance Program
  • Renal Cell Carcinoma Copay Assistance Program
  • Rett Syndrome Financial Assistance Program
  • Sarcoidosis Copay Assistance Program
  • Short Bowel Syndrome Financial Assistance Program
  • Sickle Cell Disease Financial Assistance Program
  • Small Cell Lung Cancer Copay Assistance Program
  • Systemic Sclerosis Financial Assistance Program
  • Thrombocytopenia Copay Assistance Program
  • Thyroid Cancer Copay Assistance Program
  • Thyroid Eye Disease Financial Assistance Program
  • Tumor-Induced Osteomalacia Financial Assistance Program
  • Ulcerative Colitis Copay Assistance Program
  • Urea Cycle Disorders Financial Assistance Program

If you do not see your disease program listed above, please click here to visit the blue reenrollment group.

Purple Reenrollment Group Now Closed

Reenrollment Time Period: Wednesday, November 6 (12 p.m. ET) through Friday, November 22 (7 p.m. ET)

The reenrollment time period for the purple group is CLOSED. Use the “Reenrollment Hub” button below to check the status of your application for reenrollment.

TAF expects to finalize renewed 2025 program participation by: January 13, 2025.*

Reenrollment Hub
Reenrollment FAQs

Am I eligible to apply for reenrollment?

You are eligible to apply for 2025 disease program participation if you:

  • are actively enrolled in an eligible purple disease program;
  • are a U.S. citizen or permanent resident;
  • have been diagnosed with the disease state for which you are applying to reenroll; and
  • have been prescribed an FDA-approved treatment for the disease and have health insurance that covers the prescribed medication.

How do I apply for reenrollment?

Once the reenrollment window opens, you can apply for reenrollment by using one of the following methods:

Text:

If we have your cell phone on file, you may receive your unique reenrollment link by text.

  • Step 1: Prior to November 6, you must text “REENROLL25” to (833) 585-0336.
  • Step 2: You will receive a text confirming you have opted to receive text communications from TAF.
  • Step 3: On November 6, if you’ve opted in, you will receive a text message with your unique reenrollment link at 12 p.m. ET.

Email:

If we have an email for you on file, TAF will send a reenrollment link to that email address on November 6 at 12 p.m. ET. To confirm that the email address we have for you is up to date, please call (855) 845-3663 to speak with a Patient Advocate.

Paper:

If you wish to complete a paper application, please call (833) 343-2148.

Paper applications must be requested and will not be provided prior to November 6.

TAF expects to finalize renewed 2025 program participation by: January 13, 2025.*

* This date is subject to change. You may receive correspondence regarding your renewed 2025 disease program participation by mail, text, or email.